0001104659-22-061939.txt : 20220517
0001104659-22-061939.hdr.sgml : 20220517
20220517160901
ACCESSION NUMBER: 0001104659-22-061939
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220514
FILED AS OF DATE: 20220517
DATE AS OF CHANGE: 20220517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paterson Dan
CENTRAL INDEX KEY: 0001563202
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35403
FILM NUMBER: 22934519
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 440
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER NAME:
FORMER CONFORMED NAME: Paterson Daniel
DATE OF NAME CHANGE: 20130314
FORMER NAME:
FORMER CONFORMED NAME: Paterson Dan
DATE OF NAME CHANGE: 20121128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verastem, Inc.
CENTRAL INDEX KEY: 0001526119
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273269467
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 500
CITY: NEEDHAM
STATE: MA
ZIP: 02494
BUSINESS PHONE: (781) 292-4200
MAIL ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 500
CITY: NEEDHAM
STATE: MA
ZIP: 02494
4
1
tm2215781-3_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2022-05-14
0
0001526119
Verastem, Inc.
VSTM
0001563202
Paterson Dan
C/O VERASTEM, INC., 117 KENDRICK ST.,
SUITE 500
NEEDHAM
MA
02494
0
1
0
0
President and COO
Common Stock
2022-05-14
4
A
0
15000
0.00
A
492933
D
Common Stock
2022-05-16
4
S
0
4988
1.03
D
487945
D
- Represents performance-based restricted stock units ("PRSUs") granted to the Reporting Person on June 24, 2021 under the Issuer's 2021 Equity Incentive Plan. Each PRSU represents the right to receive one share of Common Stock. On May 14, 2022 the Compensation Committee of the Issuer's Board of Directors certified that the PRSUs' performance criteria had been satisfied and the PRSUs vested in full.
- The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.
/s/ Robert E. Gagnon, Attorney-in-Fact
2022-05-17